Table 1 Clinical characteristics of two clusters of BC patients
| Â | Feature | Cluster 2 | Cluster 1 | P-value |
|---|---|---|---|---|
Age | Meidan (IQR) | 69.4 (60.9, 76.5) | 69 (60.7, 76.9) | 0.986 |
Gender, n (%) | Female | 60 (14.7%) | 47 (11.5%) | Â |
Male | 184 (45.1%) | 117 (28.7%) | 0.423 | |
Race, n (%) | Asian | 14 (3.6%) | 30 (7.7%) | Â |
Black or African American | 13 (3.3%) | 10 (2.6%) | Â | |
White | 207 (52.9%) | 117 (29.9%) |  < 0.001 | |
pathologic stage, n (%) | Stage I | 2 (0.5%) | 0 (0%) | Â |
Stage II | 69 (17%) | 61 (15%) | Â | |
Stage III | 82 (20.2%) | 58 (14.3%) | Â | |
Stage IV | 90 (22.2%) | 44 (10.8%) | 0.066 | |
Grade, n (%) | High Grade | 236 (58.3%) | 148 (36.5%) | Â |
Low Grade | 6 (1.5%) | 15 (3.7%) | 0.006 |